Related Experiment Videos

Prophylaxis of chronic lung disease after premature birth

A Greenough1

  • 1Division of Women's & Children's Health, Guy's King's & St Thomas' School of Medicine, King's College Hospital, London SE5 9RS, UK. anne.greenough@kcl.ac.uk

Insights

Preventing chronic lung disease in premature infants is challenging. While high-frequency ventilation and early systemic corticosteroids show promise, their long-term safety and efficacy require further investigation for vulnerable newborns.

Area of Science:

  • Neonatal Medicine
  • Pediatric Pulmonology
  • Critical Care

Background:

  • Chronic lung disease (CLD) is a significant complication for premature infants, often resulting from neonatal intensive care interventions like volutrauma and oxygen toxicity.
  • Infants born at very early gestations are particularly susceptible to developing CLD.

Purpose of the Study:

  • To review prophylactic strategies for preventing CLD in premature infants.
  • To evaluate the effectiveness and safety of high-frequency oscillation and early systemic corticosteroids.

Main Methods:

  • Systematic review of randomized trials investigating prophylactic strategies for CLD.
  • Analysis of data on clinical outcomes, including CLD incidence, mortality, intracranial pathology, pulmonary function, and neurodevelopmental outcomes.

Main Results:

  • High-frequency oscillation, with a high volume strategy, may reduce CLD incidence but raises concerns about increased intracranial pathology in very immature infants.
  • Early systemic corticosteroids appear to reduce CLD and mortality, but long-term pulmonary and neurodevelopmental effects warrant caution.

Conclusions:

  • Current prophylactic strategies for CLD in premature infants lack definitive evidence of both efficacy and safety.
  • Further research is needed to optimize ventilation strategies and understand the long-term implications of corticosteroid therapy in extremely preterm infants.

Related Concept Videos